Greenberg Traurig is a Contributing Sponsor of the 2026 ConV2X Smart Technology Transformation in Healthcare, taking place October 29–30. Charles Dunham will serve as a panelist for “When AI Becomes Medicine: Who Decides What Is Safe Enough?”
The discussion will explore the growing role of AI in clinical decision-making, diagnostics, and patient care, including when AI-powered software may be considered a medical device. Panelists will examine key issues surrounding regulatory approval, explainability, bias, model risk, clinical responsibility, and accountability when AI-supported decisions result in patient harm.